Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Dermatology

Vol. 232, No. 3, 2016

Issue release date: June 2016

Add all to MyReading List
FREE ONLINE ACCESS
Review Paper
259

What Is New in Melanoma Genetics and Treatment?

Ribero S. · Longo C. · Glass D. · Nathan P. · Bataille V.
Dermatology 2016;232:259-264 (DOI:10.1159/000445767)
link Key Message: News in genetics and treatment of skin melanoma.
Free Access
Original Paper
265

ING4 Inhibits Proliferation and Induces Apoptosis in Human Melanoma A375 Cells via the Fas/Caspase-8 Apoptosis Pathway

Ma Y. · Cheng X. · Wang F. · Pan J. · Liu J. · Chen H. · Wang Y. · Cai L.
Dermatology 2016;232:265-272 (DOI:10.1159/000444050)
link -Key Message: Apoptotic effects of ING4 on human malignant melanoma cells via the Fas/caspase-8 pathway.
Free Supplementary Material
Free Access
273

Dermoscopic and Immunohistochemical Changes in Acquired Melanocytic Nevi following Narrow-Band Ultraviolet B Therapy

Zaher H. · Bassiouny D. · Abdel Hay R. · Samir N. · Ragab N. · Sayed S.
Dermatology 2016;232:273-278 (DOI:10.1159/000445780)
Free Access
Skin Cancer - Original Paper
279

Squamocellular Carcinoma of the Skin: Clinicopathological Features Predicting the Involvement of the Surgical Margins and Review of the Literature

Ribero S. · Osella Abate S. · Di Capua C. · Dika E. · Balagna E. · Senetta R. · Picciotto F. · Tomasini C. · Macripo G. · Quaglino P.
Dermatology 2016;232:279-284 (DOI:10.1159/000444051)
Free Access
Original Paper
285

Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort

Rehefeldt-Erne S. · Nägeli M.C. · Winterton N. · Felderer L. · Weibel L. · Hafner J. · Dummer R.
Dermatology 2016;232:285-292 (DOI:10.1159/000444792)
Free Access
293

Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma

Guinard E. · Legendre L. · Kramkimel N. · Avril M.F. · Chassaing N. · Cabaret O. · Guillaud-Bataille M. · Mazereeuw Hautier J.
Dermatology 2016;232:293-297 (DOI:10.1159/000445430)
Free Access
Review Paper
298

Dynamic Optical Coherence Tomography in Dermatology

Ulrich M. · Themstrup L. · de Carvalho N. · Manfredi M. · Grana C. · Ciardo S. · Kästle R. · Holmes J. · Whitehead R. · Jemec G.B.E. · Pellacani G. · Welzel J.
Dermatology 2016;232:298-311 (DOI:10.1159/000444706)
link Key Message: Dynamic optical coherence tomography allows new insights into the vascular morphology of neoplastic as well as inflammatory skin diseases at the subclinical level and may help distinguish between benign and malignant skin lesions.
Free Access
Original Paper
312

Investigation of Enthesopathy with Ultrasonography and Comparison with Skin Findings in Asymptomatic Psoriatic Patients

Oğuz I.D. · Gül Ü. · Koparal S.S. · Deren T. · Külcü Çakmak S. · Bodur H. · Yilmaz Ö.
Dermatology 2016;232:312-318 (DOI:10.1159/000444218)
Free Access
Review Paper
319

Oral Psoriasis: An Overlooked Enigma

Fatahzadeh M. · Schwartz R.A.
Dermatology 2016;232:319-325 (DOI:10.1159/000444850)
link Key Message: The oral cavity of patients with known psoriasis should be routinely examined as part of any dermatological evaluation.
Free Access
Clinical Investigations
326

Patient Adherence to Biologic Agents in Psoriasis

Hsu D.Y. · Gniadecki R.
Dermatology 2016;232:326-333 (DOI:10.1159/000444581)
Free Access
Original Paper
334

Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study

Radtke M.A. · Spehr C. · Reich K. · Rustenbach S.J. · Feuerhahn J. · Augustin M.
Dermatology 2016;232:334-343 (DOI:10.1159/000444635)
Free Access
Review Paper
344

Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies

Andersen L.K. · Davis M.D.P.
Dermatology 2016;232:344-352 (DOI:10.1159/000444580)
Free Access
353

Effectiveness of Barrier Creams against Irritant Contact Dermatitis

Mostosi C. · Simonart T.
Dermatology 2016;232:353-362 (DOI:10.1159/000444219)
Free Access
Original Paper
363

Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease

Wang C.-P. · Lu Y.-C. · Tsai I-T. · Tang W.-H. · Hsu C.-C. · Hung W.-C. · Yu T.-H. · Chen S.-C. · Chung F.-M. · Lee Y.-J. · Houng J.-Y.
Dermatology 2016;232:363-370 (DOI:10.1159/000445429)
Free Access
Review Paper
371

How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy

Dressler C. · Rosumeck S. · Nast A.
Dermatology 2016;232:371-380 (DOI:10.1159/000446069)
link Key Message: The best evidence available for acne maintenance treatment is for the combination benzoyl peroxide/adapalene and adapalene monotherapy.
Free Supplementary Material
Free Access
Letter to Dermatology
381

Hidradenitis Suppurativa: Terminology

Revuz J.
Dermatology 2016;232:381 (DOI:10.1159/000445739)
link Key Message: Describing clinical lesions of hidradenitis suppurativa is a challenge.
Free Access
Letter to Dermatology / Reply
382

Reply to Revuz' Letter Entitled ‘Hidradenitis Suppurativa: Terminology'

Lipsker D.
Dermatology 2016;232:382 (DOI:10.1159/000445740)
link Key Message: Palpable lesions, fistulas, tunnels and suppuration are defined in hidradenitis suppurativa.
Free Access
Letter to Dermatology
383

Response to the Commentary of Naldi and Cazzaniga Entitled ‘Are All Screening Programmes Created Equal? The Case of Melanoma'

Cristofolini M. · Boi S. · Cattoni D. · Sicher M.C. · Decarli A. · Micciolo R.
Dermatology 2016;232:383 (DOI:10.1159/000444707)
link Key Message: In these patients, total skin examination could be performed every 2-3 years.
Free Access
Letter to Dermatology / Reply
384

Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled ‘Are All Screening Programmes Created Equal? The Case of Melanoma'

Naldi L. · Cazzaniga S.
Dermatology 2016;232:384 (DOI:10.1159/000444708)
link Key Message: We should move forward from pioneering experiences in melanoma prevention.
Free Access